Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Cathinone or Nootropic or Sedative-Hypnotic

Use the filters below to narrow your results.

generic:
brand:
None (36) · (none, never marketed) (1) · Dalmane (1) · Doral (1) · Doriden (1) · Halcion (1) · Hetlioz (1) · Imovane (1) · Lunesta (1) · Mogadon (1) · Nembutal (1) · Placidyl (1) · ProSom (1) · Quaalude (1) · Restoril (1) · Rohypnol (1) · Rozerem (1) · Seconal (1) · Sonata (1) · THIP (1) · Versed (1) · Xyrem (1)
classes: (Click arrow to add another value)
mechanism:
None (2) · ACTH analogue; BDNF upregulator (1) · AMPA modulator; catecholaminergic (1) · AMPA receptor modulator (1) · AMPA receptor positive allosteric modulator (2) · AMPA/NMDA modulator; NGF/BDNF upregulation (1) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and serotonin reuptake inhibitor; actoprotector (1) · Extremely potent GABAA positive allosteric modulator (1) · GABAA positive allosteric modulator (15) · GABAA positive allosteric modulator (non-benzodiazepine) (3) · GABAA positive allosteric modulator; very long half-life (1) · GABAA potentiator (1) · GABAA potentiator and direct activator (2) · GABAB agonist; alpha-2-delta calcium channel ligand (1) · GABAB agonist; GHB receptor agonist (1) · Glutamate receptor antagonist; GABA modulator (1) · High-affinity choline uptake enhancer (2) · Melatonin receptor agonist (2) · Monoamine releasing agent (4) · Monoamine releasing agent; active ingredient in khat (1) · Norepinephrine and dopamine releasing agent (1) · Norepinephrine/dopamine releasing agent (1) · Norepinephrine/dopamine reuptake inhibitor (1) · Positive allosteric modulator of the GABA<sub>A</sub> receptor at the benzodiazepine binding site; increases frequency of Cl<sup>−</sup> channel opening, producing anxiolytic, sedative, hypnotic, anticonvulsant, and skeletal-muscle relaxant effects. (1) · Prodrug of modafinil (1) · Selective GABAA agonist (extrasynaptic delta subunit) (1) · Serotonin precursor; 5-hydroxytryptophan (1) · Serotonin releasing agent; monoamine reuptake inhibitor (1) · Serotonin/norepinephrine/dopamine releasing agent (3)
uses:
None (56) · No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1)
starting dose:
None (56) · No medical dose. Active recreational doses reported in the 0.5–1.5 mg range (similar potency to alprazolam). (1)
preparations:
None (56) · Illicit tablets ("bars"), powders, blotter, occasionally solutions. No pharmaceutical product exists. (1)
fda max:
None (56) · N/A (never approved) (1)
routes:
None (56) · intranasal; rectal and IV reported. (1) · Oral (1) · sublingual (1)
onset:
None (56) · ~20–40 min PO; faster sublingual/intranasal. (1)
duration:
None (56) · 6–10 h subjective; full pharmacologic effect considerably longer. (1)
halflife:
None (56) · Estimated ~12–17 h (some sources cite up to ~21 h); active metabolites prolong effect. (1)
bioavailability:
None (56) · Not formally characterized in humans. (1)
pregnancy:
None (56) · Avoid. Benzodiazepines are associated with neonatal sedation, floppy-infant syndrome, and withdrawal; teratogenic signal weak but non-zero. Designer benzo with no safety data, assume worst-case. (1)
legal:
None (57)

Showing below up to 57 results in range #1 to #57.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"